Literature DB >> 3679037

Study of cathepsin A, B and D activities in the skin wound edges. Its application to the differential diagnosis between vital and postmortem wounds.

C Hernández-Cueto1, A Luna, J A Lorente, E Villanueva.   

Abstract

The aims of the authors in this paper has been to check the diagnostic ability of the Cathepsin A, B and D concentrations in the skin wound edges to the differential diagnosis between vital and postmortem wounds. We have studied 56 domestic pigs grouped in seven experimental series consisting of 8 animals in each, according to the time (0, 5, 15, 30 min and 1, 3 and 6 h) after the injury. The enzymatic activities were investigated following the methods by Bowen and Davison Biochem. J., 131 (1973) 417-419, Suhar and Marks J. Biochem., 101 (1979) 23-30 and by Anson (modified by Yamamoto, Eur. J. Biochem., 95 (1979) 459-467) for Cathepsin A, B and D, respectively. For the differential diagnosis between vital and postmortem wounds, our results showed that the most useful markers studied are the Cathepsin A and D activities, Cathepsin D that of the first one.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679037     DOI: 10.1016/0379-0738(87)90022-3

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

1.  [Release of proteinase inhibitors as a vital reaction in the early post-traumatic interval].

Authors:  M Oehmichen; V Schmidt
Journal:  Z Rechtsmed       Date:  1989

2.  The immunohistochemical localization of alpha 1-antichymotrypsin and fibronectin and its meaning for the determination of the vitality of human skin wounds.

Authors:  P Betz; A Nerlich; J Wilske; J Tübel; R Penning; W Eisenmenger
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

3.  Cathepsin D as a vitality marker in human skin wounds.

Authors:  C Hernández-Cueto; J A Lorente; I Pedal; E Villanueva; G Zimmer; E Girela; E Miltner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.